Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-05 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-05 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-05 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.19 | 4e-05 |